Список литературы

    1. Бровкина А.Ф. Офтальмоонкология: руководство для врачей / А. Ф. Бровкина, В. В. Вальский, Г. А. Гусев и др. – Москва : Медицина, 2002. – 424 p.

    2. Гончарова К.С. Социально-демографические особенности региональной дифференциации доходов населения России / Гончарова К.С. // Вестник Научноисследовательского центра корпоративного права, управления и венчурного инвестирования Сыктывкарского государственного университета. – 2019. – № 4. – С. 157-168.

    3. Гришина Е.Е. Анализ офтальмоонкологической патологии у взрослого населения Москвы по данным МОКБ / Е.Е. Гришина, О.Ф. Федотова, В.М. Житнев // Опухоли и опухолеподобные заболевания органа зрения: Cб. науч. тр. научно-практической конференции. - М., 1998. - С. 23-24

    4. Гришина Е.Е. Эпидемиология увеальной меланомы в г. Москве / Е. Е. Гришина, М. Ю. Лернер, Э. Г. Гемджян // Альманах клинической медицины. – 2017. – Т. 45. – № 4. – С. 321-325.

    5. Гришина Е.Е. Диагностика метастатической увеальной меланомы. Что изменилось за 10 лет / Е. Е. Гришина, Е. А. Степанова, А. М. Богатырев // Альманах клинической медицины. – 2020. – Т. 47. – № 8. – С. 712-720.

    6. Зарецкий А.Р. Опыт молекулярного тестирования увеальной меланомы I–III стадии при консервативном и хирургическом лечении / А. Р. Зарецкий, В. А. Яровая, Л. В. Чудакова и др. // Вопросы онкологии. – 2018. – Т. 5. – c. 625-632.

    7. Миронова И.С. Качество жизни больных увеальной меланомой в зависимости от тактики лечебных мероприятий: дис. канд. мед. наук. – М., 2016 – 151 с.

    8. Панова И.Е. Характеристика показателей качества жизни пациентов с меланомой хориоидеи при различных вариантах лечения / И. Е. Панова, А. С. Мочалова, Е. И. Гюнтнер и др. // Вестник Оренбургского государственного университета. – 2011. – Т. 133. – № 14. – С. 288-291.

    9. Саакян С.В. Анализ показателей качества жизни больных увеальной меланомой в отдаленном периоде в зависимости от возраста и вида лечения / Саакян С.В., Амирян А.Г., Миронова И.С. // Российский офтальмологический журнал. – 2016. – Т. 9. – № 1. – С. 56-61.

    10. Цыганков А.Ю. Прогностическая значимость диагностики молекулярногенетических изменений и их корреляция с клинико-морфологическими характеристиками при увеальной меланоме: дис. канд. мед. наук. – М., 2015. – 135 с. / А. Ю. 1Цыганков.

    11. Шишкин М.М., Резникова А.Б. Отдаленные результаты комбинированной эндорезекции больших меланом хориоидеи // Сб.тезисов научно-практической конференции “Современные технологии лечения витреоретинальной патологии”. М. - 2012. - С. 204-206

    12. Яровая В.А. Прогностическая тонкоигольная аспирационная биопсия увеальной меланомы: дис. канд. мед. наук. – М., 2020. – 178 с.

    13. Яровая В.А. Прогностическое значение клеточного типа увеальной меланомы / В. А. Яровая, А. В. Шацких, А. Р. Зарецкий и др. // Архив патологии. – 2021. – Т. 83. – № 4. – С. 14.

    14. Яровая В.А. Оценка диссеминации увеальной меланомы по склеральному каналу при тонкоигольной аспирационной биопсии / В. А. Яровая, А. В. Шацких и др. // Офтальмохирургия. – 2020. – № 4. – С. 63-66.

    15. Яровая В. А. Комплексный анализ прогностической значимости аберраций хромосомы 8 у пациентов с увеальной меланомой / В. А. Яровая, А. А. Яровой, Л. В. Чудакова и др. // Advances in Molecular Oncology. – 2022. – Т. 9. – № 1. – С. 57-63.

    16. Яровой А. А. Органосохраняющее и функционально-сберегающее лечение меланомы хориоидеи на основе брахитерапии с рутением-106 и лазерной транспупиллярной термотерапии: дис. докт. мед. наук. – М., 2010. – 362 с.

    17. Яровой А.А. Стереотаксическая радиохирургия «Гамма-Нож» как альтернатива энуклеации у пациентов с увеальной меланомой (первые результаты) / А. А. Яровой, А. В. Голанов, С. Р. Ильялов и др. // Офтальмохирургия. – 2014. – № 2. – С. 74-80.

    18. Яровой А.А. Эндовитреальное удаление увеальной меланомы: пятилетний опыт //Эффективная фармакотерапия. – 2016. – №. 39. – С. 64-67. / А. А. Яровой, И. М. Горшков, О. В. Голубева. – 2016. – С. 64-67.

    19. Abd ElHafeez S. Methods to Analyze Time-to-Event Data: The Cox Regression Analysis / S. Abd ElHafeez, G. D’Arrigo, D. Leonardis [et al.] // Oxidative Medicine and Cellular Longevity. – 2021. – Vol. 2021. – P. 1-6.

    20. Afshar A. R. Uveal melanoma: evidence for efficacy of therapy / A. R. Afshar, B. E. Damato // International Ophthalmology Clinics. – 2015. – Vol. 55. – № 1. – P. 23-43.

    21. Akgul H. Intraocular biopsy using special forceps: a new instrument and refined surgical technique / H. Akgul, F. Otterbach, N. Bornfeld, B. Jurklies // British Journal of Ophthalmology. – 2011. – Vol. 95. – № 1. – P. 79-82.

    22. Ali Z. Melanoma epidemiology, biology and prognosis. / Z. Ali, N. Yousaf, J. Larkin // EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]. – 2013. – Vol. 11. – № 2. – P. 81-91.

    23. Almony A. Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma / A. Almony // Archives of Ophthalmology. – 2008. – Vol. 126. – № 1. – P. 65.

    24. Amedee R. G. Fine-Needle Aspiration Biopsy / R. G. Amedee, N. R. Dhurandhar // The Laryngoscope. – 2001. – Vol. 111. – № 9. – P. 1551-1557.

    25. Andreoli M. T. Epidemiological trends in uveal melanoma / M. T. Andreoli, W. F. Mieler, Y. I. Leiderman // British Journal of Ophthalmology. – 2015. – Vol. 99. – № 11. – P. 1550-1553.

    26. Ardjomand N. Lymph node metastases arising from uveal melanoma / N. Ardjomand, P. Komericki, G. Langmann [et al.] // Wiener klinische Wochenschrift. – 2005. – Vol. 117. – № 11-12. – P. 433-435.

    27. Augsburger J. Diagnostic transvitreal fine-needle aspiration biopsy of small melanocytic choroidal tumors in nevus versus melanoma category. / J. J. Augsburger, Z. M. Correa, S. Schneider [et al.] // Transactions of the American Ophthalmological Society. – 2002. – Vol. 100. – P. 225-32.

    28. Avakyan K. The role of modern methods in early metastases diagnosis in patients with uveal melanoma / K. V. Avakyan, S. V. Saakyan, A. G. Amiryan [et al.] // Russian Electronic Journal of Radiology. – 2016. – Vol. 6. – № 4. – P. 8-18.

    29. Bagger M. M. Intraocular biopsy of uveal melanoma Risk assessment and identification of genetic prognostic markers / M. M. Bagger // Acta Ophthalmologica. – 2018. – Vol. 96. – P. 1-28.

    30. Balch C. Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System / C. M. Balch, S.-J. Soong, J. E. Gershenwald [et al.] // Journal of Clinical Oncology. – 2001. – Vol. 19. – № 16. – P. 3622-3634.

    31. Beran T. Reactions to and Desire for Prognostic Testing in Choroidal Melanoma Patients / T. M. Beran, T. A. McCannel, A. L. Stanton [et al.] // Journal of Genetic Counseling. – 2009. – Vol. 18. – № 3. – P. 265-274.

    32. Berus T. Clinical, Histopathological and Cytogenetic Prognosticators in Uveal Melanoma – A Comprehensive Review / T. Berus, A. Halon, A. Markiewicz [et al.] // Anticancer Research. – 2017. – Vol. 37. – № 12.

    33. Brewington B. Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions / B. Y. Brewington, Y. F. Shao, F. H. Davidorf, C. M. Cebulla // Clinical Ophthalmology. – 2018. – Vol. Volume 12. – P. 925-934.

    34. Broggi G. Histopathology and Genetic Biomarkers of Choroidal Melanoma / G. Broggi, A. Russo, M. Reibaldi [et al.] // Applied Sciences. – 2020. – Vol. 10. – № 22. – P. 8081.

    35. Bronkhorst I. H. G. Uveal Melanoma: The Inflammatory Microenvironment / I. H. G. Bronkhorst, M. J. Jager // Journal of Innate Immunity. – 2012. – Vol. 4. – № 5- 6. – P. 454-462.

    36. Callender Colonel G. R. Five Hundred Melanomas of the Choroid and Ciliary Body Followed Five Years Or Longer / G. R. Callender Colonel, H. C. Wilder, J. E. Ash // American Journal of Ophthalmology. – 1942. – Vol. 25. – № 8. – P. 962-967.

    37. Caminal J. M. Epibulbar Seeding at the Site of a Transvitreal Fine-Needle Aspiration Biopsy / J. M. Caminal // Archives of Ophthalmology. – 2006. – Vol. 124. – № 4. – P. 587.

    38. Carvajal R. Metastatic disease from uveal melanoma: treatment options and future prospects / R. D. Carvajal, G. K. Schwartz, T. Tezel [et al.] // British Journal of Ophthalmology. – 2017. – Vol. 101. – № 1. – P. 38-44.

    39. Chang M. Y. Comparison of uveal melanoma cytopathologic sample retrieval in trans-scleral versus vitrectomy-assisted transvitreal fine needle aspiration biopsy / M. Y. Chang, T. A. McCannel // British Journal of Ophthalmology. – 2014. – Vol. 98. – № 12. – P. 1654-1658.

    40. Char D. Iris ring melanoma: fine needle biopsy. / D. H. Char, A. E. Kemlitz, T. Miller, J. B. Crawford // The British journal of ophthalmology. – 2006. – Vol. 90. – № 4. – P. 420-2.

    41. Char D. Irradiated Uveal Melanomas: Cytopathologic Correlation With Prognosis / D. H. Char, S. M. Kroll, T. Miller [et al.] // American Journal of Ophthalmology. – 1996. – Vol. 122. – № 4. – P. 509-513.

    42. Cohen V. Transvitreal fine needle aspiration biopsy: The influence of intraocular lesion size on diagnostic biopsy result / V. M. L. Cohen, S. Dinakaran, M. A. Parsons, I. G. Rennie // Eye. – 2001. – Vol. 15. – № 2. – P. 143-147.

    43. Coleman K. Prognostic Value of Morphometric Features and the Callender Classification in Uveal Melanomas / K. Coleman, J. P. A. Baak, P. J. van Diest, J. Mullaney // Ophthalmology. – 1996. – Vol. 103. – № 10. – P. 1634-1641.

    44. Collaborative Ocular Melanoma Study Group. Assessment of Metastatic Disease Status at Death in 435 Patients With Large Choroidal Melanoma in the Collaborative Ocular Melanoma Study (COMS) / Collaborative Ocular Melanoma Study Group // Archives of Ophthalmology. – 2001. – Vol. 119. – № 5. – P. 670.

    45. Collaborative Ocular Melanoma Study Group. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma / Collaborative Ocular Melanoma Study Group // Ophthalmology. – 2012. – Vol. 8. – № 119. – P. 1596-603.

    46. Collaborative Ocular Melanoma Study Group. Design and methods of a clinical trial for a rare condition: The collaborative ocular melanoma study / Collaborative Ocular Melanoma Study Group // Controlled Clinical Trials. – 1993. – Vol. 14. – № 5. – P. 362-391.

    47. Collaborative Ocular Melanoma Study Group. Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma / Collaborative Ocular Melanoma Study Group // Archives of Ophthalmology. – 2005. – Vol. 123. – № 12. – P. 1639.

    48. Collaborative Ocular Melanoma Study Group. Screening for Metastasis From Choroidal Melanoma: The Collaborative Ocular Melanoma Study Group Report 23 / Collaborative Ocular Melanoma Study Group // Journal of Clinical Oncology. – 2004. – Vol. 22. – № 12. – P. 2438-2444.

    49. Collaborative Ocular Melanoma Study Group. The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma, III: Initial Mortality Findings / Collaborative Ocular Melanoma Study Group // Archives of Ophthalmology. – 2001. – Vol. 119. – № 7. – P. 969.

    50. Collaborative Ocular Melanoma Study Group. The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma / Collaborative Ocular Melanoma Study Group // Archives of Ophthalmology. – 2006. – Vol. 124. – № 12. – P. 1684.

    51. Collaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma / M. D. Onken, L. A. Worley, D. H. Char [et al.] // Ophthalmology. – 2012. – Vol. 119. – № 8.

    52. Cook S. Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research / S. A. Cook, B. Damato, E. Marshall, P. Salmon // Eye. – 2009. – Vol. 23. – № 3. – P. 581-585.

    53. Correa Z. M. Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications / Z. M. Correa, J. J. Augsburger // Graefe’s Archive for Clinical and Experimental Ophthalmology. – 2014. – Vol. 252. – № 1. – P. 131- 135.

    54. Coupland S. E. Routes of Extraocular Extension of Uveal Melanoma / S. E. Coupland, I. Campbell, B. Damato // Ophthalmology. – 2008. – Vol. 115. – № 10. – P. 1778-1785.

    55. Cunha Rola A. Multicenter External Validation of the Liverpool Uveal Melanoma Prognosticator Online: An OOG Collaborative Study / A. Cunha Rola, A. Taktak, A. Eleuteri [et al.] // Cancers. – 2020. – Vol. 12. – № 2. – P. 477.

    56. Damato B. Cytogenetics of Uveal Melanoma / B. Damato, C. Duke, S. E. Coupland [et al.] // Ophthalmology. – 2007. – Vol. 114. – № 10. – P. 1925-1931.e1.

    57. Damato B. Local tumor control after 106Ru brachytherapy of choroidal melanoma / B. Damato, I. Patel, I. R. Campbell [et al.] // International Journal of Radiation Oncology*Biology*Physics. – 2005. – Vol. 63. – № 2. – P. 385-391.

    58. Decatur C. Driver Mutations in Uveal Melanoma / C. L. Decatur, E. Ong, N. Garg [et al.] // JAMA Ophthalmology. – 2016. – Vol. 134. – № 7. – P. 728.

    59. Demirci H. Ring melanoma of the ciliary body: report on twenty-three patients / H. Demirci, C. L. Shields, J. A. Shields [et al.] // Retina. – 2002. – Vol. 22. – № 6. – P. 698-706.

    60. DeParis S. External Validation of the Liverpool Uveal Melanoma Prognosticator Online / S. W. DeParis, A. Taktak, A. Eleuteri [et al.] // Investigative Opthalmology & Visual Science. – 2016. – Vol. 57. – № 14. – P. 6116.

    61. Diener-West M. A Review of Mortality From Choroidal Melanoma / M. DienerWest // Archives of Ophthalmology. – 1992. – Vol. 110. – № 2. – P. 245.

    62. Dogrusoz M. Genetic prognostication in uveal melanoma / M. Dogrusoz, M. J. Jager // Acta Ophthalmologica. – 2018. – Vol. 96. – № 4. – P. 331-347.

    63. Dogrusoz M. Uveal melanoma treatment and prognostication / M. Dogrusoz, M. J. Jager, B. Damato // The Asia-Pacific Journal of Ophthalmology. – 2017. – Vol. 6. – №. 2. – P. 186-196.

    64. Dono M. Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma / M. Dono, G. Angelini, M. Cecconi [et al.] // British Journal of Cancer. – 2014. – Vol. 110. – № 4. – P. 1058-1065.

    65. Durante M. Single-cell analysis reveals new evolutionary complexity in uveal melanoma / M. A. Durante, D. A. Rodriguez, S. Kurtenbach [et al.] // Nature Communications. – 2020. – Vol. 11. – № 1. – P. 496.

    66. Egan K. Epidemiologic aspects of uveal melanoma / K. M. Egan, J. M. Seddon, R. J. Glynn [et al.] // Survey of Ophthalmology. – 1988. – Vol. 32. – № 4. – P. 239- 251.

    67. Egger E. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma / E. Egger, A. Schalenbourg, L. Zografos [et al.] // International Journal of Radiation Oncology*Biology*Physics. – 2001. – Vol. 51. – № 1. – P. 138-147.

    68. Eide N. Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review / N. Eide, L. Walaas // Acta Ophthalmologica. – 2009. – Vol. 87. – № 6. – P. 588-601.

    69. Eleuteri A. Enhancing survival prognostication in patients with choroidal melanoma by integrating pathologic, clinical and genetic predictors of metastasis / A. Eleuteri, B. Damato, S. E. Coupland, A. F. G. Taktak // International Journal of Biomedical Engineering and Technology. – 2012. – Vol. 8. – № 1. – P. 18.

    70. Eskelin S. Tumor doubling times in metastatic malignant melanoma of the uvea Tumor progression before and after treatment / S. Eskelin // Ophthalmology. – 2000. – Vol. 107. – № 8. – P. 1443-1449.

    71. Finn A. P. Choroidal tumor biopsy: A Review of the Current State and a Glance Into Future Techniques. / A. P. Finn, M. A. Materin, P. Mruthyunjaya // Retina (Philadelphia, Pa.). – 2018. – Vol. 38 Suppl 1. – P. S79-S87.

    72. Folberg R. The Prognostic Value of Tumor Blood Vessel Morphology in Primary Uveal Melanoma / R. Folberg, V. Rummelt, R. Parys-Van Ginderdeuren [et al.] // Ophthalmology. – 1993. – Vol. 100. – № 9. – P. 1389-1398.

    73. Frizziero L. Uveal Melanoma Biopsy: A Review / L. Frizziero, E. Midena, S. Trainiti [et al.] // Cancers. – 2019. – Vol. 11. – № 8. – P. 1075.

    74. Furney S. SF3B1 mutations are associated with alternative splicing in uveal melanoma. / S. J. Furney, M. Pedersen, D. Gentien [et al.] // Cancer discovery. – 2013. – Vol. 3. – № 10. – P. 1122-1129.

    75. Gambrelle J. Survival after primary enucleation for choroidal melanoma: changes induced by the introduction of conservative therapies / J. Gambrelle, J. D. Grange, M. Devouassoux Shisheboran [et al.] // Graefe’s Archive for Clinical and Experimental Ophthalmology. – 2007. – Vol. 245. – № 5. – P. 657-663.

    76. Gill H. S. Uveal melanoma prognostication: from lesion size and cell type to molecular class / H. S. Gill, D. H. Char // Canadian Journal of Ophthalmology. – 2012. – Vol. 47. – № 3. – P. 246-253.

    77. Glasgow B. Quantitation of Tumor Seeding From Fine Needle Aspiration of Ocular Melanomas / B. J. Glasgow, H. H. Brown, A. Maria Zargoza, R. Y. Foos // American Journal of Ophthalmology. – 1988. – Vol. 105. – № 5. – P. 538-546.

    78. Grewal D. S. Outcomes of 27-Gauge Vitrectomy-Assisted Choroidal and Subretinal Biopsy / D. S. Grewal, T. J. Cummings, P. Mruthyunjaya // Ophthalmic Surgery, Lasers and Imaging Retina. – 2017. – Vol. 48. – № 5. – P. 406-415.

    79. Group C.O.M.S. Accuracy of Diagnosis of Choroidal Melanomas in the Collaborative Ocular Melanoma Study / C. O. M. S. Group // Archives of Ophthalmology. – 1990. – Vol. 108. – № 9. – P. 1268.

    80. Gunduz K. Exoresection and endoresection for uveal melanoma / K. Gunduz, N. Bechrakis // Middle East African Journal of Ophthalmology. – 2010. – Vol. 17. – № 3. – P. 210.

    81. Hanahan D. Hallmarks of Cancer: New Dimensions / D. Hanahan // Cancer Discovery. – 2022. – Vol. 12. – № 1. – P. 31-46.

    82. Hanahan D. Hallmarks of Cancer: The Next Generation / D. Hanahan, R. A. Weinberg // Cell. – 2011. – Vol. 144. – № 5. – P. 646-674.

    83. Hanahan D. The Hallmarks of Cancer / D. Hanahan, R. A. Weinberg // Cell. – 2000. – Vol. 100. – № 1. – P. 57-70.

    84. Hoiom V. The genetics of uveal melanoma: current insights / V. Hoiom, H. Helgadottir // The Application of Clinical Genetics. – 2016. – Vol. Volume 9. – P. 147- 155.

    85. Im D. Potential of Aqueous Humor as a Liquid Biopsy for Uveal Melanoma / D. H. Im, C.-C. Peng, L. Xu [et al.] // International Journal of Molecular Sciences. – 2022. – Vol. 23. – № 11. – P. 6226.

    86. Jager M. J. The Cancer Genome Atlas Project: An Integrated Molecular View of Uveal Melanoma / M. J. Jager, N. J. Brouwer, B. Esmaeli // Ophthalmology. – 2018. – Vol. 125. – № 8.

    87. Jager M. Uveal melanoma / M. J. Jager, C. L. Shields, C. M. Cebulla [et al.] // Nature Reviews Disease Primers. – 2020. – Vol. 6. – № 1.

    88. Jensen O. A. Malignant melanomas of the human uvea / O. A. Jensen // Acta Ophthalmologica. – 2009. – Vol. 48. – № 6. – P. 1113-1128.

    89. Jensen O. A. Late complications of biopsy in intraocular tumors / O. A. Jensen, S. R. Andersen // Acta Ophthalmologica. – 2009. – Vol. 37. – № 5. – P. 568-575.

    90. Jin E. Liquid Biopsy in Uveal Melanoma: Are We There Yet? / E. Jin, J. V. Burnier // Ocular Oncology and Pathology. – 2021. – Vol. 7. – № 1. – P. 1-16.

    91. Johansson P. Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4 / P. Johansson, L. G. Aoude, K. Wadt [et al.] // Oncotarget. – 2016. – Vol. 7. – № 4.

    92. Jovanovic P. Ocular melanoma: an overview of the current status. / P. Jovanovic, M. Mihajlovic, J. Djordjevic-Jocic [et al.] // International journal of clinical and experimental pathology. – 2013. – Vol. 6. – № 7. – P. 1230-44.

    93. Kaliki S. Influence of Age on Prognosis of Young Patients with Uveal Melanoma: A Matched Retrospective Cohort Study / S. Kaliki, C. L. Shields, A. Mashayekhi [et al.] // European Journal of Ophthalmology. – 2013. – Vol. 23. – № 2. – P. 208-216.

    94. Kaliki S. Uveal melanoma: Estimating prognosis / S. Kaliki, C. Shields, J. Shields // Indian Journal of Ophthalmology. – 2015. – Vol. 63. – № 2. – P. 93.

    95. Kim R. Histopathologic Analysis of Transvitreal Fine Needle Aspiration Biopsy Needle Tracts for Uveal Melanoma / R. S. Kim, P. Chevez-Barrios, M. E. Bretana [et al.] // American Journal of Ophthalmology. – 2017. – Vol. 174. – P. 9-16.

    96. Kujala E. Very Long-Term Prognosis of Patients with Malignant Uveal Melanoma / E. Kujala, T. Ma¨kitie, T. Kivela¨ // Investigative Opthalmology & Visual Science. – 2003. – Vol. 44. – № 11. – P. 4651.

    97. Lake S. Multiplex Ligation-Dependent Probe Amplification Analysis of Uveal Melanoma with Extraocular Extension Demonstrates Heterogeneity of Gross Chromosomal Abnormalities / S. L. Lake, B. E. Damato, J. Dopierala [et al.] // Investigative Opthalmology & Visual Science. – 2011. – Vol. 52. – № 8. – P. 5559.

    98. Lane A. M. Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma / A. M. Lane, I. K. Kim, E. S. Gragoudas // JAMA Ophthalmology. – 2018. – Vol. 136. – № 9. – P. 981.

    99. Lange M. Digital PCR-Based T-cell Quantification–Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma / M. J. de Lange, R. J. Nell, R. N. Lalai [et al.] // Molecular Cancer Research. – 2018. – Vol. 16. – № 12. – P. 1902-1911.

    100. Lange M. J. de. Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma / M. J. de Lange, R. J. Nell, P. A. van der Velden // Molecular Biomedicine. – 2021. – Vol. 2. – № 1. – P. 25.

    101. Mallet J. Implication of ultraviolet light in the etiology of uveal melanoma: A review / J. D. Mallet, S. P. Gendron, M.-C. Drigeard Desgarnier, P. J. Rochette // Photochemistry and Photobiology. – 2014. – Vol. 90. – № 1. – P. 15-21.

    102. Margo C. E. The Collaborative Ocular Melanoma Study: An Overview / C. E. Margo // Cancer Control. – 2004. – Vol. 11. – № 5. – P. 304-309.

    103. Martin M, Maßhöfer L, Temming P et al. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. / et al. Martin M, Maßhöfer L, Temming P // Nat Genet. – 2013. – Vol. 45. – № 8. – P. 933- 936.

    104. Martin R. Is incisional biopsy of melanoma harmful? / R. C. G. Martin, C. R. Scoggins, M. I. Ross [et al.] // The American Journal of Surgery. – 2005. – Vol. 190. – № 6. – P. 927-932.

    105. Mazloumi M. Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma / M. Mazloumi, P. Vichitvejpaisal, L. A. Dalvin, A. Yaghy // JAMA Ophthalmology. – 2020. – Vol. 138. – № 3. – P. 260.

    106. McCannel T. A. Multi-Year Follow-up of Fine-Needle Aspiration Biopsy in Choroidal Melanoma / T. A. McCannel, M. Y. Chang, B. L. Burgess // Ophthalmology. – 2012. – Vol. 119. – № 3. – P. 606-610.

    107. McLean I. Modifications of Callender’s Classification of Uveal Melanoma at the Armed Forces Institute of Pathology / I. W. McLean, W. D. Foster, L. E. Zimmerman, J. W. Gamel // American Journal of Ophthalmology. – 2018. – Vol. 195. – P. lvi-lx.

    108. Medina C. Diagnostic Cytologic Features of Uveal Melanoma / C. A. Medina, C. V. Biscotti, N. Singh, A. D. Singh // Ophthalmology. – 2015. – Vol. 122. – № 8. – P. 1580-1584.

    109. Midena E. Biopsies in Uveal Melanoma / E. Midena, R. Parrozzani // Current Concepts in Uveal Melanoma. – 2011. – P. 81-95.

    110. Miller A. Uveal Melanoma with Histopathologic Intratumoral Heterogeneity Associated with Gene Expression Profile Discordance / A. K. Miller, M. J. Benage, D. J. Wilson, A. H. Skalet // Ocular Oncology and Pathology. – 2017. – Vol. 3. – № 2. – P. 156-160.

    111. Modorati G. Gamma Knife Radiosurgery for Uveal Melanoma: A Retrospective Review of Clinical Complications in a Tertiary Referral Center / G. M. Modorati, R. Dagan, L. H. Mikkelsen [et al.] // Ocular Oncology and Pathology. – 2020. – Vol. 6. – № 2. – P. 115-122.

    112. Molenkamp B. Non-Radical Diagnostic Biopsies Do Not Negatively Influence Melanoma Patient Survival / B. G. Molenkamp, B. J. R. Sluijter, B. Oosterhof [et al.] // Annals of Surgical Oncology. – 2007. – Vol. 14. – № 4. – P. 1424-1430.

    113. Moore A. Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma / A. R. Moore, E. Ceraudo, J. J. Sher [et al.] // Nature Genetics. – 2016. – Vol. 48. – № 6. – P. 675-680.

    114. Nayman T. Uveal Melanoma Risk Factors: A Systematic Review of MetaAnalyses / T. Nayman, C. Bostan, P. Logan, M. N. Burnier // Current Eye Research. – 2017. – Vol. 42. – № 8. – P. 1085-1093.

    115. Ndulue J. Ciliary Body Seeding after Pars Plana Transvitreal Fine-Needle Aspiration Biopsy of Choroidal Melanoma / J. Ndulue, A. Mashayekhi, C. L. Shields // Journal of Ophthalmic and Vision Research. – 2020.

    116. Olopade O. I. Cancer genetics in oncology practice / O. I. Olopade, G. Pichert // Annals of Oncology. – 2001. – Vol. 12. – № 7. – P. 895-908.

    117. Pach J. Prognostic Factors in Choroidal and Ciliary Body Melanomas With Extrascleral Extension / J. M. Pach, D. M. Robertson, B. S. Taney [et al.] // American Journal of Ophthalmology. – 1986. – Vol. 101. – № 3. – P. 325-331.

    118. Pandiani C. Focus on cutaneous and uveal melanoma specificities / C. Pandiani, G. E. Beranger, J. Leclerc [et al.] // Genes & Development. – 2017. – Vol. 31. – № 8. – P. 724-743.

    119. Parella P. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization / P. Parrella, O. L. Caballero, D. Sidransky, S. L. Merbs // Investigative ophthalmology & visual science. – 2001. – Vol. 42. – № 8. – P. 1679-84.

    120. Paul E. V. Prognosis of malignant melanomas of the choroid and ciliary body / E. V. Paul, B. L. Parnell, M. Fraker // International Ophthalmology Clinics. – 1962. – Vol. 2. – № 2. – P. 387-402.

    121. Prognosis of Uveal Melanoma in 500 Cases Using Genetic Testing of FineNeedle Aspiration Biopsy Specimens / C. L. Shields, A. Ganguly, C. G. Bianciotto [et al.] // Ophthalmology. – 2011. – Vol. 118. – № 2. – P. 396-401.

    122. Radivoyevitch T. Uveal melanoma: Long-term survival / T. Radivoyevitch, E. C. Zabor, A. D. Singh // PLOS ONE. – 2021. – Vol. 16. – № 5. – P. e0250939.

    123. Raja V. Extraocular seeding of choroidal melanoma after a transretinal biopsy with a 25-gauge vitrector / V. Raja, A. Russo, S. Coupland [et al.] // RETINAL Cases & Brief Reports. – 2011. – Vol. 5. – № 3. – P. 194-196.

    124. Reddy D. Vitrectomy and Vitrector Port Needle Biopsy of Choroidal Melanoma for Gene Expression Profile Testing Immediately before Brachytherapy / D. M. Reddy, L. B. Mason, J. O. Mason [et al.] // Ophthalmology. – 2017. – Vol. 124. – № 9. – P. 1377-1382.

    125. Reichstein D. New concepts in the molecular understanding of uveal melanoma / D. Reichstein // Current Opinion in Ophthalmology. – 2017. – Vol. 28. – № 3. – P. 219-227.

    126. Rietschel P. Variates of Survival in Metastatic Uveal Melanoma / P. Rietschel, K. S. Panageas, C. Hanlon [et al.] // Journal of Clinical Oncology. – 2005. – Vol. 23. – № 31. – P. 8076-8080.

    127. Robertson A. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma / A. G. Robertson, J. Shih, C. Yau [et al.] // Cancer Cell. – 2017. – Vol. 32. – № 2. – P. 204-220.e15.

    128. Royer-Bertrand B. Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing / B. Royer-Bertrand, M. Torsello, D. Rimoldi [et al.] // The American Journal of Human Genetics. – 2016. – Vol. 99. – № 5. – P. 1190-1198.

    129. Schmittel A. Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma / A. Schmittel, N. E. Bechrakis, P. Martus [et al.] // European Journal of Cancer. – 2004. – Vol. 40. – № 16. – P. 2389-2395.

    130. Seddon J. A Prognostic Factor Study of Disease-Free Interval and Survival Following Enucleation for Uveal Melanoma / J. M. Seddon, D. M. Albert, P. T. Lavin, N. Robinson // Archives of Ophthalmology. – 1983. – Vol. 101. – № 12. – P. 1894- 1899.

    131. Seddon J. M. Death From Uveal Melanoma / J. M. Seddon // Archives of Ophthalmology. – 1987. – Vol. 105. – № 6. – P. 801.

    132. Seregard S. Prognostic indicators following enucleation for posterior uveal melanoma / S. Seregard, E. Kock // Acta Ophthalmologica Scandinavica. – 2009. – Vol. 73. – № 4. – P. 340-344.

    133. Shah C. Intermittent and Chronic Ultraviolet Light Exposure and Uveal Melanoma / C. P. Shah, E. Weis, M. Lajous [et al.] // Ophthalmology. – 2005. – Vol. 112. – № 9. – P. 1599-1607.

    134. Shain A. The genetic evolution of metastatic uveal melanoma / A. H. Shain, M. M. Bagger, R. Yu [et al.] // Nature Genetics. – 2019. – Vol. 51. – № 7. – P. 1123-1130.

    135. Shain A. The genetic evolution of metastatic uveal melanoma / A. H. Shain, M. M. Bagger, R. Yu [et al.] // Nature Genetics. – 2019. – Vol. 51. – № 7. – P. 1123-1130.

    136. Shields C. American Joint Committee on Cancer Classification of Posterior Uveal Melanoma (Tumor Size Category) Predicts Prognosis in 7731 Patients / C. L. Shields, S. Kaliki, M. Furuta [et al.] // Ophthalmology. – 2013. – Vol. 120. – № 10. – P. 2066-2071.

    137. Shields C. Choroidal melanoma: Clinical Features, Classification, and Top 10 Pseudomelanomas / C. L. Shields, J. Manalac, C. Das [et al.] // Current Opinion in Ophthalmology. – 2014. – Vol. 25. – № 3. – P. 177-185.

    138. Shields C. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases / C. L. Shields, S. Kaliki, M. Furuta [et al.] // Retina. – 2012. – Vol. 32. – № 7. – P. 1363-1372.

    139. Shields C. Cytogenetic Abnormalities in Uveal Melanoma Based on Tumor Features and Size in 1059 Patients / C. L. Shields, E. A. T. Say, M. Hasanreisoglu [et al.] // Ophthalmology. – 2017. – Vol. 124. – № 5.

    140. Shields C. Diffuse versus nondiffuse small (≤3 mm thickness) choroidal melanoma / C. L. Shields, S. Kaliki, M. Furuta, J. A. Shields // Retina. – 2013. – Vol. 33. – № 9. – P. 1763-1776.

    141. Shields C. Iris melanoma / C. L. Shields, J. A. Shields, M. Materin [et al.] // Ophthalmology. – 2001. – Vol. 108. – № 1. – P. 172-178.

    142. Shields C. L. Metastasis of Uveal Melanoma Millimeter-by-Millimeter in 8033 Consecutive Eyes / C. L. Shields // Archives of Ophthalmology. – 2009. – Vol. 127. – № 8. – P. 989.

    143. Shields C. American joint committee on cancer staging of uveal melanoma / C. Shields, P. Mellen, S. Morton // Oman Journal of Ophthalmology. – 2013. – Vol. 6. – № 2. – P. 116.

    144. Shields C. Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period / C. L. Shields, E. A. T. Say, M. Hasanreisoglu [et al.] // Ophthalmology. – 2017. – Vol. 124. – № 10.

    145. Shields C. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations / C. L. Shields, J. A. Shields, N. Perez [et al.] // Ophthalmology. – 2002. – Vol. 109. – № 2. – P. 225-234.

    146. Shields C. Prognosis of Uveal Melanoma in 500 Cases Using Genetic Testing of Fine-Needle Aspiration Biopsy Specimens / C. L. Shields, A. Ganguly, C. G. Bianciotto [et al.] // Ophthalmology. – 2011. – Vol. 118. – № 2.

    147. Shields C. Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review / C. Shields, L. Dalvin, P. Vichitvejpaisal [et al.] // Indian Journal of Ophthalmology. – 2019. – Vol. 67. – № 12. – P. 1959.

    148. Shields C. Small Choroidal Melanoma with Chromosome 3 Monosomy on FineNeedle Aspiration Biopsy / C. L. Shields, M. A. Materin, L. Teixeira [et al.] // Ophthalmology. – 2007. – Vol. 114. – № 10. – P. 1919-1924.

    149. Shields J. The Differential Diagnosis of Posterior Uveal Melanoma / J. A. Shields, J. J. Augsburger, G. C. Brown, R. F. Stephens // Ophthalmology. – 1980. – Vol. 87. – № 6. – P. 518-522.

    150. Shoushtari A. N. GNAQ and GNA11 mutations in uveal melanoma / A. N. Shoushtari, R. D. Carvajal // Melanoma Research. – 2014. – Vol. 24. – № 6. – P. 525- 534.

    151. Shoushtari A. N. GNAQ and GNA11 mutations in uveal melanoma / A. N. Shoushtari, R. D. Carvajal // Melanoma Research. – 2014. – Vol. 24. – № 6. – P. 525- 534.

    152. Sidawy M. K. Fine-needle aspiration of thyroid nodules / M. K. Sidawy, D. M. Del Vecchio, S. M. Knoll // Cancer. – 1997. – Vol. 81. – № 4. – P. 253-259.

    153. Silva-Rodriguez P. GNAQ and GNA11 Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma / P. SilvaRodriguez, D. Fernandez-Diaz, M. Bande [et al.] // Cancers. – 2022. – Vol. 14. – № 13. – P. 3066.

    154. Simpson E. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma / E. R. Simpson, B. Gallie, N. Laperrierre [et al.] // Brachytherapy. – 2014. – Vol. 13. – № 1. – P. 1-14.

    155. Singh A. Uveal Melanoma: Epidemiologic Aspects / A. Singh, L. Bergman, S. Seregard // Ophthalmology Clinics of North America. – 2005. – Vol. 18. – № 1. – P. 75-84.

    156. Singh A. Chromosomal 3 and 8 status within hepatic metastasis of uveal melanoma / A. D. Singh, R. Tubbs, C. Biscotti [et al.] // Archives of pathology & laboratory medicine. – 2009. – Vol. 133. – № 8. – P. 1223-7.

    157. Singh A. Congenital uveal melanoma? / A. D. Singh, L. A. Schoenfield, B. C. Bastian [et al.] // Survey of Ophthalmology. – 2016. – Vol. 61. – № 1. – P. 59-64.

    158. Singh A. D. Prognostic factors in uveal melanoma / A. D. Singh, C. L. Shields, J. A. Shields // Melanoma Research. – 2001. – Vol. 11. – № 3. – P. 255-263.

    159. Singh A. D. Uveal Melanoma: Trends in Incidence, Treatment, and Survival / A. D. Singh, M. E. Turell, A. K. Topham // Ophthalmology. – 2011. – Vol. 118. – № 9. – P. 1881-1885.

    160. Singh A. D. Estimating Cured Fractions of Uveal Melanoma / A. D. Singh, E. C. Zabor, T. Radivoyevitch // JAMA Ophthalmology. – 2021. – Vol. 139. – № 2.

    161. Singh A. Fine-needle aspiration biopsy of uveal melanoma: outcomes and complications / A. D. Singh, C. A. Medina, N. Singh [et al.] // British Journal of Ophthalmology. – 2016. – Vol. 100. – № 4. – P. 456-462.

    162. Singh A. Fine Needle Aspiration Biopsy in Uveal Melanoma: Technique, Complications, and Outcomes / A. Sellam, L. Desjardins, R. Barnhill [et al.] // American Journal of Ophthalmology. – 2016. – Vol. 162. – P. 28-34.e1.

    163. Singh A. The Collaborative Ocular Melanoma Study / A. Singh, T. Kivela // Ophthalmology Clinics of North America. – 2005. – Vol. 18. – № 1. – P. 129-142.

    164. Singh A. Primary transpupillary thermotherapy of “small” choroidal melanoma: is it safe? / A. D. Singh, T. Kivela, S. Seregard [et al.] // British Journal of Ophthalmology. – 2008. – Vol. 92. – № 6. – P. 727-728.

    165. Singh A. Uveal melanoma in young patients / A. D. Singh, C. L. Shields, J. A. Shields, T. Sato // Archives of ophthalmology (Chicago, Ill. : 1960). – 2000. – Vol. 118. – № 7. – P. 918-23.

    166. Souri Z. Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma / Z. Souri, A. P. A. Wierenga, C. van Weeghel [et al.] // Cancers. – 2019. – Vol. 11. – № 8. – P. 1102.

    167. Traine P. Biopsy with the New Essen Biopsy Forceps / P. G. Traine, K. J. E. Schedler, M. G. S. Brusa, E. B. Rodrigues // Case Reports in Ophthalmological Medicine. – 2013. – Vol. 2013. – P. 1-3.

    168. Uveal melanoma: From diagnosis to treatment and the science in between / C. Chattopadhyay, D. W. Kim, D. S. Gombos [et al.] // Cancer. – 2016. – Vol. 122. – № 15. – P. 2299-2312.

    169. Vichitvejpaisal P. Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D / P. Vichitvejpaisal, L. A. Dalvin, M. Mazloumi [et al.] // Ophthalmology. – 2019. – Vol. 126. – № 10.

    170. Virgili G. Incidence of Uveal Melanoma in Europe / G. Virgili, G. Gatta, L. Ciccolallo [et al.] // Ophthalmology. – 2007. – Vol. 114. – № 12. – P. 2309-2315.e2.

    171. Yang J. Treatment of uveal melanoma: where are we now? / J. Yang, D. K. Manson, B. P. Marr, R. D. Carvajal // Therapeutic Advances in Medical Oncology. – 2018. – Vol. 10. – P. 175883401875717.

    172. Yarovoy A. A. Which Choroidal Melanoma Should be Treated with Primary Transpupillary Thermotherapy? Our Experience from 78 Patients / A. A. Yarovoy, D. A. Magaramov, E. S. Bulgakova // European Journal of Ophthalmology. – 2010. – Vol. 20. – № 1. – P. 186-193.

    173. Yavuzyigitoglu S. Uveal Melanomas with SF3B1 Mutations / S. Yavuzyigitoglu, A. E. Koopmans, R. M. Verdijk [et al.] // Ophthalmology. – 2016. – Vol. 123. – № 5. – P. 1118-1128.

    174. Young T. Transscleral Fine-Needle Aspiration Biopsy of Macular Choroidal Melanoma / T. A. Young, B. L. Burgess, N. P. Rao [et al.] // American Journal of Ophthalmology. – 2008. – Vol. 145. – № 2. – P. 297-302.e1.

    175. Zloto O. Gender Differences in Clinical Presentation and Prognosis of Uveal Melanoma / O. Zloto, J. Pe’er, S. Frenkel // Investigative Opthalmology & Visual Science. – 2013. – Vol. 54. – № 1. – P. 652.